Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
Background. So-called rational drug design is suboptimal when it comes to finding effective and safe drug-based treatment for COVID-19. Another approach seems promising: to reprofile the pharmaceuticals registered in the Anatomical, Therapeutic, and Chemical Classifier (ATC).Material and methods. Ch...
Saved in:
Main Authors: | I. Yu. Torshin (Author), O. A. Gromova (Author), A. G. Chuchalin (Author), Yu. I. Zhuravlev (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022) -
Chemoreactomic study of fonturacetam effects: molecular mechanisms of influence on adipose tissue metabolism
by: O. A. Gromova, et al.
Published: (2024) -
Comparative chemoreactome analysis of mexidol
by: I. J. Torshin, et al.
Published: (2016) -
Chemoreactomic analysis of the antioxidant properties of vitamin B12 derivatives
by: I. Yu. Torshin, et al.
Published: (2023) -
Chemoreactome analysis of 7-hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate
by: I. Yu. Torshin, et al.
Published: (2020)